Companies / Dianthus Therapeutics, Inc. / Activity
Activity — Dianthus Therapeutics, Inc.
40 moves.
Top impactInsider · CEO movesInsider · biggest buysInsider · biggest sellsInstitution · biggest movesInstitution · new positions
| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 12, 2026 | Garcia Marino CEO | Sell | Common Stock | $16.7K | -200 -18.18% | 900 <0.01% of shares | low |
| Mar 12, 2026 | Carr Edward Executive | Sell | Common Stock | $16.7K | -200 -40.00% | 300 <0.01% of shares | low |
| Mar 12, 2026 | Carr Edward Executive | Sell | Common Stock | $25.7K | -300 -100.00% | 0 0.00% of shares | low |
| Mar 12, 2026 | Randhawa Simrat Executive | Exercise | Common Stock | $67.5K | +8K | 7,998 0.01% of shares | low |
| Mar 12, 2026 | Garcia Marino CEO | Sell | Common Stock | $77.0K | -900 -100.00% | 0 0.00% of shares | low |
| Mar 12, 2026 | Randhawa Simrat Executive | Exercise | Common Stock | $89.4K | +5K +62.52% | 12,998 0.02% of shares | low |
| Mar 16, 2026 | Garcia Marino CEO | Exercise | Common Stock | $100.0K | +6K +9.37% | 65,292 0.12% of shares | low |
| Mar 12, 2026 | Randhawa Simrat Executive | Exercise | Common Stock | $181.4K | +8K +64.10% | 21,330 0.04% of shares | low |
| Mar 12, 2026 | Carr Edward Executive | Exercise | Common Stock | $217.7K | +10K +29.69% | 43,682 0.08% of shares | low |
| Mar 24, 2026 | Soteropoulos Paula Director | Exercise | Common Stock | $232.9K | +28K | 27,594 0.05% of shares | low |
| Mar 12, 2026 | Randhawa Simrat Executive | Exercise | Common Stock | $275.9K | +13K +58.60% | 33,830 0.06% of shares | low |
| Mar 12, 2026 | Carr Edward Executive | Exercise | Common Stock | $289.3K | +16K | 16,182 0.03% of shares | low |
| Mar 12, 2026 | Carr Edward Executive | Sell | Common Stock | $319.5K | -4K -88.55% | 500 <0.01% of shares | medium |
| Mar 12, 2026 | Carr Edward Executive | Exercise | Common Stock | $386.2K | +18K +108.14% | 33,682 0.06% of shares | low |
| Mar 16, 2026 | Garcia Marino CEO | Exercise | Common Stock | $400.0K | +60K | 59,700 0.11% of shares | low |
| Mar 12, 2026 | Garcia Marino CEO | Exercise | Common Stock | $823.6K | +123K | 122,918 0.22% of shares | low |
| Mar 12, 2026 | Garcia Marino CEO | Sell | Common Stock | $1.06M | -13K -92.08% | 1,100 <0.01% of shares | medium |
| Mar 12, 2026 | Carr Edward Executive | Sell | Common Stock | $1.28M | -16K -36.29% | 27,830 0.05% of shares | medium |
| Mar 12, 2026 | Carr Edward Executive | Sell | Common Stock | $1.92M | -23K -84.32% | 4,365 <0.01% of shares | medium |
| Mar 24, 2026 | Soteropoulos Paula Director | Sell | Common Stock | $2.15M | -28K -100.00% | 0 0.00% of shares | medium |
| Mar 12, 2026 | Randhawa Simrat Executive | Sell | Common Stock | $2.76M | -34K -100.00% | 0 0.00% of shares | medium |
| Mar 12, 2026 | Garcia Marino CEO | Sell | Common Stock | $3.51M | -44K -35.39% | 79,413 0.14% of shares | medium |
| Mar 12, 2026 | Garcia Marino CEO | Sell | Common Stock | $5.36M | -66K -82.50% | 13,896 0.02% of shares | medium |
| May 21, 2026 | Kango Sujay Director | Grant | Stock Option (Right to Buy) | — | +6K | 6,090 0.01% of shares | low |
| Feb 3, 2026 | Veness Adam M Executive | Grant | Stock Option (Right to Buy) | — | +100K | 100,000 0.18% of shares | low |
| Mar 24, 2026 | Soteropoulos Paula Director | Exercise | Stock Option (Right to Buy) | — | -28K -95.84% | 1,198 <0.01% of shares | low |
| Mar 16, 2026 | Garcia Marino CEO | Exercise | Stock Option (Right to Buy) | — | -6K -2.03% | 269,408 0.48% of shares | low |
| Mar 16, 2026 | Garcia Marino CEO | Exercise | Stock Option (Right to Buy) | — | -60K -99.93% | 41 <0.01% of shares | low |
| Mar 12, 2026 | Randhawa Simrat Executive | Exercise | Stock Option (Right to Buy) | — | -13K -10.53% | 106,250 0.19% of shares | low |
| Mar 12, 2026 | Randhawa Simrat Executive | Exercise | Stock Option (Right to Buy) | — | -8K -13.33% | 54,174 0.10% of shares | low |
| Mar 12, 2026 | Randhawa Simrat Executive | Exercise | Stock Option (Right to Buy) | — | -5K -6.56% | 71,184 0.13% of shares | low |
| Mar 12, 2026 | Randhawa Simrat Executive | Exercise | Stock Option (Right to Buy) | — | -8K -66.67% | 3,998 <0.01% of shares | low |
| Mar 12, 2026 | Garcia Marino CEO | Exercise | Stock Option (Right to Buy) | — | -123K -67.29% | 59,741 0.11% of shares | low |
| Mar 12, 2026 | Carr Edward Executive | Exercise | Stock Option (Right to Buy) | — | -10K -16.67% | 50,000 0.09% of shares | low |
| Mar 12, 2026 | Carr Edward Executive | Exercise | Stock Option (Right to Buy) | — | -18K -29.17% | 42,500 0.08% of shares | low |
| Mar 12, 2026 | Carr Edward Executive | Exercise | Stock Option (Right to Buy) | — | -16K -20.23% | 63,818 0.11% of shares | low |
| Feb 3, 2026 | Savitz Ryan Executive | Grant | Stock Option (Right to Buy) | — | +150K | 150,000 0.27% of shares | low |
| Feb 3, 2026 | Randhawa Simrat Executive | Grant | Stock Option (Right to Buy) | — | +150K | 150,000 0.27% of shares | low |
| Feb 3, 2026 | Garcia Marino CEO | Grant | Stock Option (Right to Buy) | — | +355K | 355,000 0.63% of shares | low |
| Feb 3, 2026 | Carr Edward Executive | Grant | Stock Option (Right to Buy) | — | +55K | 55,000 0.10% of shares | low |